BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32771526)

  • 1. HOTAIR maintains the stemness of ovarian cancer stem cells via the miR-206/TBX3 axis.
    Zhang Y; Guo J; Cai E; Cai J; Wen Y; Lu S; Li X; Han Q; Jiang J; Li T; Wang Z
    Exp Cell Res; 2020 Oct; 395(2):112218. PubMed ID: 32771526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of long non-coding RNA HOTAIR reverses cisplatin resistance of ovarian cancer cells through inhibiting miR-138-5p-regulated EZH2 and SIRT1.
    Zhang Y; Ai H; Fan X; Chen S; Wang Y; Liu L
    Biol Res; 2020 Apr; 53(1):18. PubMed ID: 32349783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
    Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
    Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice.
    Yang C; Li H; Zhang T; Chu Y; Chen D; Zuo J
    J Cell Biochem; 2020 Feb; 121(2):1514-1523. PubMed ID: 31535411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.
    Huang Y; Wang L; Liu D
    Cell Cycle; 2021 Oct; 20(19):1999-2009. PubMed ID: 34470574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor-2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin.
    He M; Wu H; Jiang Q; Liu Y; Han L; Yan Y; Wei B; Liu F; Deng X; Chen H; Zhao L; Wang M; Wu X; Yao W; Zhao H; Chen J; Wei M
    Mol Oncol; 2019 Feb; 13(2):403-421. PubMed ID: 30536571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
    Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
    Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Ovarian Cancer Stem Cells by Dual Inhibition of HOTAIR and DNA Methylation.
    Wang W; Fang F; Ozes A; Nephew KP
    Mol Cancer Ther; 2021 Jun; 20(6):1092-1101. PubMed ID: 33785648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of long non-coding RNA HOTAIR inhibits invasion and migration of oesophageal cancer cells via up-regulation of microRNA-204.
    Wang AH; Tan P; Zhuang Y; Zhang XT; Yu ZB; Li LN
    J Cell Mol Med; 2019 Oct; 23(10):6595-6610. PubMed ID: 31389660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer.
    Li J; Yang S; Su N; Wang Y; Yu J; Qiu H; He X
    Tumour Biol; 2016 Feb; 37(2):2057-65. PubMed ID: 26341496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HOTAIR controls the expression of Rab22a by sponging miR-373 in ovarian cancer.
    Zhang Z; Cheng J; Wu Y; Qiu J; Sun Y; Tong X
    Mol Med Rep; 2016 Sep; 14(3):2465-72. PubMed ID: 27484896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA BACE1-AS is a novel target for anisomycin-mediated suppression of ovarian cancer stem cell proliferation and invasion.
    Chen Q; Liu X; Xu L; Wang Y; Wang S; Li Q; Huang Y; Liu T
    Oncol Rep; 2016 Apr; 35(4):1916-24. PubMed ID: 26783004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer.
    Teschendorff AE; Lee SH; Jones A; Fiegl H; Kalwa M; Wagner W; Chindera K; Evans I; Dubeau L; Orjalo A; Horlings HM; Niederreiter L; Kaser A; Yang W; Goode EL; Fridley BL; Jenner RG; Berns EM; Wik E; Salvesen HB; Wisman GB; van der Zee AG; Davidson B; Trope CG; Lambrechts S; Vergote I; Calvert H; Jacobs IJ; Widschwendter M
    Genome Med; 2015 Oct; 7():108. PubMed ID: 26497652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells.
    Yue Y; Xia L; Xu S; Wang C; Wang X; Lu W; Xie X
    J Gynecol Oncol; 2020 Jul; 31(4):e46. PubMed ID: 32026660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contrary functions of lncRNA HOTAIR/miR-17-5p/PTEN axis and Shenqifuzheng injection on chemosensitivity of gastric cancer cells.
    Jia J; Zhan D; Li J; Li Z; Li H; Qian J
    J Cell Mol Med; 2019 Jan; 23(1):656-669. PubMed ID: 30338929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anisomycin inhibits the activity of human ovarian cancer stem cells via regulating antisense RNA NCBP2-AS2/MEK/ERK/STAT3 signaling.
    Ling L; Wen Y; Xiong Y; Liu X; Chen J; Liu T; Zhang B
    J Gene Med; 2024 Jan; 26(1):e3571. PubMed ID: 37483091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p.
    Wang C; Qi S; Xie C; Li C; Wang P; Liu D
    J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.